Peritoneal Cancer
3000-02-006: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)
- Details
ClinicalTrials.gov ID:
NCT03955471
Diagnosis Type:
NA
USOR Number:
- Address
11850 Blackfoot St NW, Suite 100
Coon
Rapids, MN 55433
P: (763) 712-2100